Form 4 Filing for Steve E. Krognes at Guardant Health, Inc.

This Form 4 filing details transactions made by Steve E. Krognes, a director at Guardant Health, Inc. (GH), on April 30, 2026. Krognes acquired 154 shares of Common Stock and was granted 154 Restricted Stock Units (RSUs). The RSUs, granted on August 9, 2022, vest over a three-year period starting June 30, 2023, with 25% vesting on that date and the remaining 75% vesting monthly thereafter. The filing indicates direct ownership, with post-transaction holdings of 19,362 shares of Common Stock and 309 RSUs. The transactions were reported by John Saia as attorney-in-fact for Krognes.